Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 26.97 M24.15 M23.66 M25.9 M27.35 M 101.05 M Research & development ————— — Operating income 191.38 M222.49 M206.16 M179.4 M199.41 M 807.46 M Non-Operating Income, Total -53.94 M-158.08 M-56.45 M-26.15 M-8.28 M -248.96 M Interest expense, net of interest capitalized 68.8 M71.8 M75.23 M75.43 M78.46 M 300.91 M Non-Operating Income, excl. Interest Expenses -61.85 M-161.58 M-59.48 M-28.66 M-12.98 M -262.7 M Unusual income/expense 7.91 M3.5 M3.03 M2.52 M4.7 M 13.74 M Pretax income 137.45 M64.4 M149.72 M153.25 M191.13 M 558.5 M Equity in earnings 5.38 M6.16 M2.36 M4.11 M4.54 M 17.17 M Taxes 11.63 M13.09 M8.49 M-1.31 M14.63 M 34.91 M Non-controlling/minority interest -8 00092 K229 K6.24 M194 K 6.76 M After tax other income/expense ————— — Net income before discontinued operations 125.82 M51.22 M141 M148.32 M176.3 M 516.84 M Discontinued operations ————— — Net income 125.82 M51.22 M141 M148.32 M176.3 M 516.84 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 125.82 M51.22 M141 M148.32 M176.3 M 516.84 M Basic earnings per share (Basic EPS) 0.570.230.640.670.8 2.34 Diluted earnings per share (Diluted EPS) 0.570.230.640.670.8 2.34 Average basic shares outstanding 220.4 M220.57 M220.56 M220.5 M220.62 M — Diluted shares outstanding 220.72 M220.87 M221.09 M221.11 M221.62 M — EBITDA 239.38 M262.69 M250.97 M354.1 M242.11 M 1.11 B EBIT 191.38 M222.49 M206.16 M179.4 M199.41 M 807.46 M Cost of revenue 12.33 M9.87 M4.77 M218 K-655 K 14.2 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 48 M40.2 M44.8 M174.7 M42.7 M 302.4 M